An extension study of LON002 in patients with cancer.
Research type
Research Study
Full title
An extension study of LON002 in patients with cancer.
IRAS ID
164377
Contact name
Mazhar Ajaz
Contact email
Sponsor organisation
LondonPharma Ltd
Eudract number
2014-004246-10
Duration of Study in the UK
3 years, 0 months, 0 days
Research summary
This is an extension study of the sponsors medicinal product, LON002, for patients with cancer, who have previously participated in a trial (a parent study) where they have received LON002. The purpose of the study is to provide LON002 to patients who have benefitted from it, to continue taking the medicine for as long as it still helps them. It also allows further tests to be carried out, to assess the long term safety of LON002 and look at how effective LON002 is in treating cancer.
REC name
London - South East Research Ethics Committee
REC reference
15/LO/0052
Date of REC Opinion
9 Feb 2015
REC opinion
Further Information Favourable Opinion